Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV: Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism

NCT01084369 is registered in ClinicalTrials.gov with Tameside Hospital NHS Foundation Trust as lead sponsor.

NCT NCT01084369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01084369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV: Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Lead sponsor
Tameside Hospital NHS Foundation Trust
Phase
Phase 4
Overall status
Terminated
Start date
October 11, 2013
Completion date
September 14, 2014
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, type 2 diabetes